Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1003 | 1052 | 1092 | 712 | 823 | 1217 |
Fund Return | 0.33% | 5.16% | 9.21% | -10.7% | -3.81% | 1.98% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HGlobal EM Equity Class IC | 376.29M | 4.28 | -7.65 | 2.98 | ||
HGlobal EM Equity Class S1D | 376.29M | 4.36 | -7.45 | 3.20 | ||
HSBC Glbl EM Eq Class PD AUD | 376.29M | 4.15 | -7.97 | 2.63 | ||
HSBC Glbl EM Eq Class PC AUD | 376.29M | 4.16 | -7.97 | 2.62 | ||
Funds Global Emerging Markets Equia | 376.29M | 4.59 | -6.80 | 3.85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock World Healthscience A2 | 77.34M | -2.52 | 9.61 | - | ||
CapGroup NewPerspectiveLux Cadh AUD | 14.09B | 1.23 | 3.73 | - | ||
Investec Global Franchise A Inc2 | 8.34B | 1.14 | 3.36 | - | ||
AB FCP I AmerGrwth Pf AD AUD H Inc | 7.5B | 3.69 | 6.61 | - | ||
BlackRockGlblEnhancedEqYld A8 AUD H | 297.17M | 2.97 | 4.14 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Reliance Industries | INE002A01018 | 7.81 | 2,869.65 | -0.06% | |
ITAUUNIBANCOPN EB N1 | BRITUBACNPR1 | 5.70 | 33.23 | +0.03% | |
Tencent Holdings Ltd | - | 5.44 | - | - | |
PETROBRAS PN | BRPETRACNPR6 | 4.97 | 36.69 | -1.66% | |
Alibaba Group Holding Ltd Ordinary Shares | - | 4.49 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review